Abstract LB217: Novel organoid models of lineage plasticity in castration resistant prostate cancer
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-lb217
Abstract: The development of next-generation AR-targeted drugs, such as abiraterone and enzalutamide, has improved survival of patients with castration-resistant prostate cancer (CRPC). However, many patients eventually progress to therapy-resistant lethal prostate cancer. CRPC exhibits variant cellular… read more here.
Keywords: cancer; lineage plasticity; dnpc; prostate cancer ... See more keywords